Dizal Pharmaceutical(SH:688192) Xin Lang Cai Jing·2025-05-01 01:31Group 1 - Dize Pharmaceutical (688192.SH) reported its Q1 2025 results, with 57 institutional investors holding a total of 334 million shares, representing 80.01% of the company's total equity [1] - The top ten institutional investors collectively hold 73.98% of Dize Pharmaceutical's shares, with a slight increase of 0.11 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, 17 funds increased their holdings, accounting for a 0.86% increase, with notable funds including Yongying Medical Innovation Mixed Fund A and Ping An Medical Health Mixed A [2] - Conversely, 13 public funds reduced their holdings, representing a 0.12% decrease, with key funds including Bosera Health Growth and Penghua Innovation Medical Mixed A [2] - Six new public funds disclosed their holdings this period, while 239 funds were not disclosed compared to the previous quarter [2]